» Articles » PMID: 16459490

Piracetam--an Old Drug with Novel Properties?

Overview
Journal Acta Pol Pharm
Specialties Pharmacology
Pharmacy
Date 2006 Feb 8
PMID 16459490
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Piracetam (2-oxo-1-pyrrolidine-acetamide), the most common of the nootropic drugs, is a cyclic derivative of gamma-aminobutyric acid. The treatment with piracetam improves learning, memory, brain metabolism, and capacity. Piracetam has been shown to alter the physical properties of the plasma membrane by increasing its fluidity and by protecting the cell against hypoxia. It increases red cell deformability and normalizes aggregation of hyperactive platelets. Piracetam is an agent with antithrombotic, neuroprotective and rheological properties. The interaction of this molecule with the membrane phospholipids restores membrane fluidity and could explain the efficacy of piracetam in various disorders ranging from dementia and vertigo to myoclonus and stroke.

Citing Articles

Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.

Malik M, Tlustos P Nutrients. 2022; 14(16).

PMID: 36014874 PMC: 9415189. DOI: 10.3390/nu14163367.


Effects of Smart Drugs on Cholinergic System and Non-Neuronal Acetylcholine in the Mouse Hippocampus: Histopathological Approach.

Satoh R, Kawakami K, Nakadate K J Clin Med. 2022; 11(12).

PMID: 35743382 PMC: 9224974. DOI: 10.3390/jcm11123310.


Evaluation of Nootropic Activity of Against Scopolamine-induced Amnesia in Rats.

Mali K, V Sutar G, Dias R, Devade O Turk J Pharm Sci. 2021; 18(1):3-9.

PMID: 33631923 PMC: 7957316. DOI: 10.4274/tjps.galenos.2019.30316.


Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1.

Kouga T, Koizume S, Aoki S, Jimbo E, Yamagata T, Inoue K Mol Genet Metab Rep. 2019; 20:100474.

PMID: 31110947 PMC: 6510973. DOI: 10.1016/j.ymgmr.2019.100474.


Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial.

Arhami Dolatabadi A, Larimi S, Safaie A Arch Acad Emerg Med. 2019; 7(1):e9.

PMID: 30847444 PMC: 6377226.